Navigating the Biosimilars MarketByAlan SheppardSeptember 2nd 2011The market landscape for biosimilars is in flux, with limited penetration now, but with the potential for growth for those who can navigate the market. Plus: A SWOT analysis of biosimilars by Anjan Selz.